Watson news
News from watson pharmaceuticals
Watson Pharmaceuticals, Inc. Adjusts FY 2009 GAAP EPS Guidance To A Range Below Analysts' Estimates; Reaffirms FY 2009 Revenue, Non-GAAP EPS And EBITDA Guidance
Watson Reports Third Quarter 2009 GAAP EPS of $0.55; Adjusted EPS of $0.66
Watson Reports Third Quarter 2009 GAAP EPS of $0.55; Adjusted EPS of $0.66
SYS-CON Media - 4 minutes ago
MORRISTOWN, NJ, Nov. 4 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today reported net income of $63.0 million, or $0.55 per diluted share for the third quarter ended ...
Watson Pharmaceuticals names new senior vice president and CFO
Watson Pharmaceuticals names new senior vice president and CFO
Trading Markets - 4 minutes ago
Nov 02, 2009 (Datamonitor via COMTEX) -- WPI -- Watson Pharmaceuticals, a US-based specialty pharmaceutical company, has appointed Todd Joyce as its new senior vice president and CFO. Mr Joyce ...
Watson Pharmaceuticals, Inc. Announces Appointment Of Chief Financial Officer
Watson Pharmaceuticals, Inc. Announces Appointment Of Chief Financial Officer
Reuters Key Development - 1 hour ago
Watson and Barr Pharmaceutical settle patent lawsuit
Watson and Barr Pharmaceutical settle patent lawsuit
Trading Markets - 18 hours ago
Oct 30, 2009 (Datamonitor via COMTEX) -- WPI -- Watson Pharmaceuticals, a specialty pharmaceutical company, has reported that its subsidiary Watson Laboratories, has reached a settlement with Barr ...
